Clinical

Dataset Information

Study of E7070 Combined With Capecitabine to Determine Efficacy and Recommended Dose of Combination in Patients With Metastatic Colorectal Cancer


ABSTRACT: Part 1: The primary purpose is to determine the recommended dose of E7070 in combination with capecitabine by dose adjustment. Part 2: The primary purpose is to determine the safety and efficacy of the combination in patients with metastatic CRC resistant to 5-fluorouracil and irinotecan.

DISEASE(S): Colorectal Cancer (crc),Metastatic Colorectal Cancer Resistant To Or Unsuitable For Treatment With 5-fluorouracil And Irinotecan And/or Oxaliplatin,Colorectal Neoplasms

PROVIDER: 2016943 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR